Managing Principal Joshua White to Speak on European Union Guidelines on Exclusionary Abuses of Dominance During ABA Webinar
Event: Guidelines for the Perplexed (About Exclusionary Abuses) Date: 21 October 2026 Host: American Bar Association (ABA) Comments Committee, Economics Committee, International Committee, and Monopolization and Dominance Committee Times: 10:00–11:00 a.m. (GMT) / 11:00 a.m.–12:00 p.m. (CET)
Analysis Group Managing Principal Joshua White will join a webinar hosted by the ABA to discuss the European Union (EU) Guidelines on exclusionary abuses of dominance under Article 102 TFEU. Massimiliano Kadar (DG COMP) will present an overview of the guidelines, followed by a discussion moderated b0y James Modrall (Norton Rose Fulbright) and featuring Lena Hornkohl (University of Vienna).
Mr. White will discuss the Guidelines’ approach to economic evidence and analysis, including the role of economic tools in assessing objective necessity and efficiency defenses. He will also consider how the Guidelines’ treatment of efficiencies relates to the EU’s 2023 Horizontal Cooperation Guidelines and 2026 Draft Merger Guidelines.
Associated People
Joshua White
Managing PrincipalMr White is a consulting and testifying economist who specialises in applying microeconomics and sophisticated econometric modelling to complex litigation and merger-related questions, primarily in matters involving the health care, financial services and technology industries. He has supported clients in various jurisdictions and industries in follow-on competition damages litigation, assessing overcharge, upstream and downstream pass-on and volume effects. He has served as a testifying expert in the UK Upper Tribunal (Lands Chamber), the UK Competition Appeal Tribunal and the Amsterdam District Court on competition cases.
Mr White has supported high-profile companies with complex merger reviews across multiple jurisdictions, including in the Veolia/Suez, LVMH/Tiffany, Sika/MBCC and Eutelsat/OneWeb mergers. He has also provided evidence to the UK’s Competition and Markets Authority (CMA) and the European Commission (EC), including on behalf of clients involved in cartel investigations, abuse of dominance investigations and mergers. Mr White has also provided support to European financial and competition regulators in coordinated conduct investigations.
Mr White has extensive experience addressing competition and intellectual property (IP) issues in matters related to cutting-edge pharmaceutical products and FRAND licensing questions. As part of this work, he has supported a number of scientific and technical experts in front of courts and regulatory bodies. He also regularly supports pharmaceutical clients on competition issues around market access, pricing, denigration and competition from generic manufacturers.
Mr White has worked in a number of jurisdictions, including the UK, the European Union, Switzerland, Australia, New Zealand, South Africa, Canada, Japan, Korea, the Netherlands, Belgium and the US. His writing has been published in an array of journals, including the Journal of European Competition Law & Practice, the Competition Law Journal and the Journal of Antitrust Enforcement, and he regularly speaks at international competition law and policy conferences.